Fig. 3: Comparison of the PASC risks in the INSIGHT cohort versus in the OneFlorida+ cohort, from March 2020 to November 2021. | Nature Communications

Fig. 3: Comparison of the PASC risks in the INSIGHT cohort versus in the OneFlorida+ cohort, from March 2020 to November 2021.

From: Data-driven analysis to understand long COVID using electronic health records from the RECOVER initiative

Fig. 3

The incident risk was measured by the adjusted hazard ratios (aHR) with 95% confidence intervals as shown in the main panel. The adjusted cumulative incidences (CIF) per 1000 patients in both the SARS-CoV-2 positive group and the negative group were also reported. The PASC conditions identified in both datasets were marked by ‡ symbols. The color panels represent different organ systems, including (from top to bottom): the nervous system, skin, respiratory system, circulatory system, endocrine and metabolic, digestive system, genitourinary system, and other signs. The PASC outcomes were ascertained from day 30 after the SARS-CoV-2 infection and all the adjusted risk measures were computed 180 days after the SARS-CoV-2 infection. The aHRs of PASC diagnosis code U099/B948 were not illustrated here. COPD, Chronic obstructive pulmonary disease. PASC, post-acute sequelae of SARS-CoV-2 infection.

Back to article page